February 8, 2012
Hiroyuki Mitani, President and CEO, Novartis Pharma Novartis Pharma President and CEO Hiroyuki Mitani told reporters in Tokyo on February 7 that market entry by generic versions of the ARB (angiotensin receptor blocker) Diovan, which is scheduled in Japan in...read more